Reducing Brief Thermal and Electrical Pain (Four Study Days)
4DO
1 other identifier
interventional
20
1 country
1
Brief Summary
Ultimately, the purpose of the present study is to help improve pain control in burn patients during wound care and physical therapy, where pain levels with opioids alone are often excessively high. This study measures how much virtual reality pain distraction reduces pain compared to traditional opioid pain meds, and whether there is additional pain reduction when Virtual Reality distraction + Opioids are combined. In addition to studying the amount of pain reduction, this study will also measure side effects (if any) of the two treatments (Virtual Reality pain distraction and Opioids) alone and when combined. Healthy volunteers will be recruited from advertisements will undergo a trial of the pain testing. They will receive a series of brief stimuli (at a painful but tolerable safe intensities they select and approve during baseline testing), separated by intervals of no pain. Participants will rate how much pain they felt after each brief stimulus, and will fill out side effects questionnaires after finishing the pain session. Subjects will participate in each of the four conditions in which the order is randomized.
- No opioids (0ng/ml hydromorphone) + no virtual reality Snow World distraction
- No opioids + yes virtual reality Snow World distraction
- Moderate dose of pain medicine (4ng/ml hydromorphone) + no virtual reality
- Moderate dose of pain medicine + yes virtual reality Snow World distraction It is our hypothesis that VR distraction + opioids will show a reduced perception of pain in subjects more than opioids alone or no intervention (control).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pain
Started Dec 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 20, 2008
CompletedFirst Posted
Study publicly available on registry
May 22, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedSeptember 13, 2011
September 1, 2011
5 months
May 20, 2008
September 12, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of VR distraction with and without opioid when pain stimulus is applied.
at completion of study
Study Arms (1)
1
EXPERIMENTALall study participants will have 4 visits: VR alone, VR + opioid, opioid alone, and no VR/opioid
Interventions
Virtual Reality involves wearing a helmet and playing a game called "Snow world". This game has sound and is presented in 3D format. This game has immersive qualities that help user feel as if they are "in" the game.
Virtual Reality video games involve wearing a helmet with vision and sound. this game is presented in 3D which gives the user the feeling of being "in" the game. The game used for this study is "Snow World"
Eligibility Criteria
You may qualify if:
- Healthy men and women 18-45 years old
- Normal height and weight ratio
You may not qualify if:
- women who are pregnant and nursing
- history of substance abuse
- access to opioids in the workplace
- smokes cigarettes
- history of medical problems with the following: heart, lungs, liver, kidneys, endocrine, neurologic, migraines, or psychiatric requiring medical intervention
- anemia
- chronic pain
- allergy or hypersensitivity to opioids, velcro, or latex
- severe motion sickness
- unusual sensitivity or lack of sensitivity to pain
- sensitive skin or feet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Washington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel R. Sharar, MD
Professor, University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Coordinator
Study Record Dates
First Submitted
May 20, 2008
First Posted
May 22, 2008
Study Start
December 1, 2007
Primary Completion
May 1, 2008
Study Completion
December 1, 2008
Last Updated
September 13, 2011
Record last verified: 2011-09